Biomarker test company Cleveland HeartLab made a splash recently at TEDMED, with about 500 conference-goers taking the company’s heart inflammation tests.
Results of the TEDMED tests showed that 41 percent of those who submitted samples had high cholesterol or low HDL (good cholesterol), 28 percent showed evidence of hardening of the arteries and 12 percent tested positive for plaque in the arteries.
Cleveland HeartLab founder and chief science officer Dr. Marc Penn presented the results on stage at TEDMED.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
“We’re looking at classic risk factors like lipids,” Penn said. “We’re also looking at inflammatory markers that not only define whether you have hardening of the artery, but also define whether your artery is active and at-risk for a cardiovascular event, such as stroke or heart attack.”
Watch the video below to see Penn’s presentation.